Atomera (ATOM) Q4 2017 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2017 earnings summary
6 Nov, 2026Executive summary
MST is a silicon-film transistor enhancement technology aimed at improving speed, reliability and energy efficiency while using standard manufacturing equipment and requiring limited process-flow changes.
Customer engagements doubled during 2017; the first evaluation-services revenue was recognized, but commercial adoption remained the key milestone for success.
Financial highlights
FY2017 revenue was $110k, all from engineering services, versus $0 in FY2016; cost of revenue was $39k and gross margin was $71k.
Operating expenses were $13.281M versus $9.999M; operating loss was $13.210M and net loss was $13.068M, compared with $12.610M net loss in FY2016.
R&D expense rose 46% YoY to $5.8M; G&A was $5.8M and selling and marketing was $1.7M.
Cash used in operations was $9.289M; cash and cash equivalents ended FY2017 at $17.369M, with working capital of approximately $16.8M.
Outlook and guidance
Management expected available working capital to fund current plans and obligations for at least 12 months after the filing, while noting that additional capital may be needed before commercial-scale production.
2018 engineering headcount and related costs were expected to remain at or above 2017 levels; G&A was expected to increase, alongside increased R&D headcount, fabrication and testing spending.
Near-term priorities were advancing customer integration, securing a licensee and enabling full-scale industrial production; customer qualification can take 18–36 months or longer.
Latest events from Atomera
- MST advanced through customer evaluation, but commercial adoption and revenue remained unproven.ATOM
Q4 2016 - Initial licenses marked progress, but commercialization remains gated by qualification and cash burn.ATOM
Q4 2018 - Revenue grew, but losses and commercialization hurdles remained substantial.ATOM
Q4 2019 - Cash rose to $37.9 million as a paid manufacturing JDA advanced MST toward commercialization.ATOM
Q4 2020 - JDA milestones and foundry evaluation expanded prospects, but commercialization remained unproven amid $15.7M losses.ATOM
Q4 2021 - Customer milestones advanced, but commercial royalties remain unproven amid continued losses.ATOM
Q4 2022 - FY 2023 revenue was $550K as MST reached two customer fabs and advanced toward royalties.ATOM
Q4 2023 - Q3 revenue was $0 as GAA, memory and IQE-led GaN programs advanced.ATOM
Q3 2026 - Q2 2026 saw a $6.3M net loss, $158K revenue, and major MST milestones in RF and memory.ATOM
Q2 2026